Invention Grant
- Patent Title: Pyrrolopyrimidine compound
-
Application No.: US15536648Application Date: 2015-12-15
-
Publication No.: US10561657B2Publication Date: 2020-02-18
- Inventor: Li Zhu , Dengming Xiao , Yuandong Hu , Liguang Dai , Xiaowei Duan , Yinghui Sun , Yong Peng , Fansheng Kong , Hong Luo , Yongxin Han , Ling Yang , Shanchun Wang
- Applicant: CENTAURUS BIOPHARMA CO., LTD. , CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. , LIANYUNGANG RUNZHONG PHARMACEUTICAL CO., LTD.
- Applicant Address: CN Beijing CN Lianyungang CN Lianyungang
- Assignee: Centaurus Biophrama Co., Ltd.,Chia Tai Tianqing Pharmaceutical Group Co., Ltd.,Lianyungang Runzhong Pharmaceutical Co., Ltd.
- Current Assignee: Centaurus Biophrama Co., Ltd.,Chia Tai Tianqing Pharmaceutical Group Co., Ltd.,Lianyungang Runzhong Pharmaceutical Co., Ltd.
- Current Assignee Address: CN Beijing CN Lianyungang CN Lianyungang
- Agency: Kilpatrick Townsend & Stockton LLP
- Priority: CN201410784461 20141216
- International Application: PCT/CN2015/097411 WO 20151215
- International Announcement: WO2016/095805 WO 20160623
- Main IPC: A61K31/519
- IPC: A61K31/519 ; A61K31/5377 ; C07D487/04 ; A61P35/00
Abstract:
The present application relates to the field of pharmaceutical chemistry, and in particular, to a pyrrolopyrimidine compound represented by general formula (I), a stereoisomer thereof, or a pharmaceutically acceptable salt thereof. The present invention further relates to a method for preparing the pyrrolopyrimidine compound represented by general formula (I), pharmaceutical compositions and an application of the pyrrolopyrimidine compound in treating diseases mediated by Janus Kinase.
Public/Granted literature
- US20190201403A1 PYRROLOPYRIMIDINE COMPOUND Public/Granted day:2019-07-04
Information query
IPC分类:
